- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01153230
Frequencies of Histo-pathological Findings in Patients With Paraquat Toxicity
June 29, 2010 updated by: Isfahan University of Medical Sciences
Study of Frequencies of Histo-pathological Findings in Paraquat Poisoned Patients
The purpose of this study is to determine frequencies of histo-pathological findings in dead poisoned patients and evaluate their relationships with age, gender, dosage of poisoning, time of admission and time of death.
Study Overview
Status
Completed
Conditions
Detailed Description
Acute poisoning of paraquat which is taken either to commit suicide or by mistake has become a social problem in world.
The present study was conducted to determine frequencies of histo-pathological findings in dead poisoned patients and evaluate their relationships with age, gender, dosage of poisoning, time of admission and time of death.
Study Type
Observational
Enrollment (Actual)
42
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Isfahan,, Iran, Islamic Republic of
- Noor university hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
forty two poisoned patients
Description
Inclusion Criteria:
- every patients who dithionate test were positive
Exclusion Criteria:
- nothing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
poisoned patient
after patients died the pathological findings evaluated with autopsy
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
histo-pathological findings
Time Frame: 1 day after patient died
|
for evaluate of this outcome we gather autopsy data
|
1 day after patient died
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
age
Time Frame: 5 min after admission time
|
we gathered demogeraphic data such as age
|
5 min after admission time
|
|
gender
Time Frame: 5 min after admission time
|
we gathered demographic data such as gender
|
5 min after admission time
|
|
dosage of poisoning
Time Frame: 5 min after admission time
|
we gathered historical data then estimated dosage of paraquat ingestion
|
5 min after admission time
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2002
Primary Completion (Actual)
November 1, 2008
Study Completion (Actual)
November 1, 2008
Study Registration Dates
First Submitted
June 29, 2010
First Submitted That Met QC Criteria
June 29, 2010
First Posted (Estimate)
June 30, 2010
Study Record Updates
Last Update Posted (Estimate)
June 30, 2010
Last Update Submitted That Met QC Criteria
June 29, 2010
Last Verified
November 1, 2008
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ASD-1213-4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Paraquat Toxicity
-
Second Affiliated Hospital, School of Medicine,...First People's Hospital of Hangzhou; Zhejiang Provincial Hospital of TCMNot yet recruitingParaquat Poisoning
-
Ai PengCompletedPoisoning by Paraquat With Undetermined IntentChina
-
Milton S. Hershey Medical CenterCompletedChemotherapy Effect | Chemotherapeutic Toxicity | Chemotherapeutic Agent ToxicityUnited States
-
Institut Claudius RegaudSuspendedUnspecified Adult Solid Tumor, Protocol Specific | Chemotherapeutic Agent Toxicity | Renal ToxicityFrance
-
TakedaCompletedToxicityUnited States, Argentina, Poland, South Africa, Russian Federation, Netherlands, Chile, Canada, Germany, Latvia, Finland, United Kingdom, Czech Republic, Slovakia
-
N&N Pharmaceuticals Inc.Unknown
-
Affiliated Hospital to Academy of Military Medical...Ivy Institute of Stem Cells Co. LtdUnknownLung Injury | Paraquat PoisoningChina
-
Assiut UniversityNot yet recruiting
-
Centro di Riferimento Oncologico - AvianoRecruiting
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingChemotherapeutic ToxicityChina